Abbott Laboratories

World Rank (Jan-05-2024)

57

Market Cap (Jan-05-2024)

192.668 Billion USD

World Rank (Jul-30-2023)

57

Market Cap (Jul-30-2023)

196.030 Billion USD

World Rank (Jan-07-2022)

43

Market Cap (Jan-07-2022)

239.710 Billion USD

World Rank (Jan-01-2021)

49

Market Cap (Jan-01-2021)

194.060 Billion USD

Company Rank in Country in 2023

Rank in USA in July-2023 is 34

Headquarters Country

USA

Nasdaq / NYSE Code

ABT

Market Cap (Mar-08-2026)

190.38

CEO

Robert Ford

Founders

Wallace Calvin Abbott

Employee Count

115,000

Employee Count as of Date

As on Dec-2022

Headquarters City/State

Illinois

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

40,109 Million USD

Annual Operating Income in USD

6,478 Million USD

Annual Net Income in USD

5,723 Million USD

Annual Results for Period Ending

Dec-2023 ending year

Total Assets in USD

73,214 Million USD

Total Liabilities in USD

34,387 Million USD

Total Equity in USD

38,827 Million USD

Balance Sheet for Period Ending

Dec-2023 ending year

Business Sector

Company Website

Abbott - Healthcare and Pharmaceutical Company

Wikipedia

Yahoo

Yahoo @ NYSE

Facebook

Company Profile

Abbott Laboratories is USA based healthcare and pharmaceutical and is multi-national company. Abbott has presence in more than 150 countries. Key working areas of Abbott are related to Diabetes, Diagnostics, Neuro Modulation, Nutrition, Pharmaceuticals. They have over 113,000 employees as on 2021. Headquarters is in USA.

Facts About Company

As on 2022, Abbott Laboratories has 115,000 employees.

Abbott Laboratories annual revenue generated for period ending Dec-2022 was 43,653 million USD.

Abbott Laboratories annual net income generated for period ending Dec-2022 was 6,933 million USD.

Abbott Laboratories annual revenue generated for period ending Dec-2021 was 43,075 million USD.

Abbott Laboratories annual net income generated for period ending Dec-2021 was 7,071 million USD.

Total Assets as on Dec-2021 was 75,196 Million USD.

Annual Results Summary

Abbott Laboratories - Yearly Revenue and Net Profit - in Million USD:

Year - Ending	Revenue	Net Profit
Dec-2024	41,950	13,402
Dec-2023	40,109	5,723
Dec-2022	43,653	6,933
Dec-2021	43,075	7,071
Dec-2020	34,608	4,495
Dec-2019	31,904	3,687
Dec-2018	30,578	2,368
Dec-2017	27,390	477
Dec-2016	20,853	1,400

Balance Sheet Summary

Abbott Laboratories - Balance Sheet Summary - in Million USD:

Year Ending:	Total Assets	Total Liabilities	Total Equity
Dec-2024	81,414	33,513	47,901
Dec-2023	73,214	34,387	38,827
Dec-2022	74,438	37,533	36,905
Dec-2021	75,196	39,394	35,802
Dec-2020	72,548	39,764	32,784
Dec-2019	67,887	36,799	31,088
Dec-2018	67,173	36,649	30,524
Dec-2017	76,250	45,353	30,897
Dec-2016	52,666	32,128	20,538

Founded Year

1888

Institutional Investors

Top 30 Institutional Investors in ABBOTT LABORATORIES as on SEP-30-2022

RANK	INSTITUTION NAME	DATE	SHARES HELD	CHANGE (SHARES)	CHANGE (%)	VALUE (IN 1,000S)
1	VANGUARD GROUP INC	09/30/2023	15,57,65,341	28,065	0.02%	$15,265,003
2	BLACKROCK INC.	09/30/2023	13,63,91,604	-7,61,941	-0.56%	$13,366,377
3	CAPITAL RESEARCH GLOBAL INVESTORS	09/30/2023	7,90,60,836	18,35,578	2.38%	$7,747,962
4	STATE STREET CORP	09/30/2023	7,32,33,207	-15,83,902	-2.12%	$7,176,854
5	CAPITAL INTERNATIONAL INVESTORS	09/30/2023	6,28,36,937	36,58,330	6.18%	$6,158,020
6	MORGAN STANLEY	09/30/2023	3,56,40,402	-7,42,792	-2.04%	$3,492,759
7	GEODE CAPITAL MANAGEMENT, LLC	09/30/2023	3,24,23,419	5,44,462	1.71%	$3,177,495
8	WELLINGTON MANAGEMENT GROUP LLP	09/30/2023	3,12,08,711	12,98,219	4.34%	$3,058,454
9	NORTHERN TRUST CORP	09/30/2023	2,30,16,235	3,43,559	1.52%	$2,255,591
10	NORGES BANK	12/31/2022	1,72,48,522	10,12,058	6.23%	$1,690,355
11	JPMORGAN CHASE & CO	09/30/2023	1,67,35,021	17,60,322	11.76%	$1,640,032
12	WELLS FARGO & COMPANY/MN	09/30/2023	1,65,89,120	-4,95,913	-2.90%	$1,625,734
13	BANK OF AMERICA CORP /DE/	09/30/2023	1,62,76,097	-10,29,386	-5.95%	$1,595,058
14	BANK OF NEW YORK MELLON CORP	09/30/2023	1,46,03,003	-5,69,235	-3.75%	$1,431,094
15	MASSACHUSETTS FINANCIAL SERVICES CO /MA/	09/30/2023	1,35,96,988	-45,51,738	-25.08%	$1,332,505
16	STATE FARM MUTUAL AUTOMOBILE INSURANCE CO	09/30/2023	1,35,87,118	0	0%	$1,331,538
17	POLEN CAPITAL MANAGEMENT LLC	09/30/2023	1,34,80,736	-3,81,118	-2.75%	$1,321,112
18	LEGAL & GENERAL GROUP PLC	09/30/2023	1,24,25,839	-4,07,288	-3.17%	$1,217,732
19	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	09/30/2023	1,21,53,877	32,157	0.27%	$1,191,080
20	NUVEEN ASSET MANAGEMENT, LLC	09/30/2023	1,20,79,884	-5,04,217	-4.01%	$1,183,829
21	ALLIANCEBERNSTEIN L.P.	09/30/2023	1,08,82,778	7,20,015	7.09%	$1,066,512
22	AMERIPRISE FINANCIAL INC	09/30/2023	1,07,38,369	-12,12,030	-10.14%	$1,052,360
23	FISHER ASSET MANAGEMENT, LLC	09/30/2023	96,94,131	25,119	0.26%	$950,025
24	JANUS HENDERSON GROUP PLC	09/30/2023	94,38,083	-2,23,003	-2.31%	$924,932
25	FLOSSBACH VON STORCH AG	09/30/2023	90,13,790	7,41,441	8.96%	$883,351
26	GOLDMAN SACHS GROUP INC	09/30/2023	87,95,608	1,07,048	1.23%	$861,970
27	FRANKLIN RESOURCES INC	09/30/2023	81,86,315	1,35,316	1.68%	$802,259
28	AMUNDI	09/30/2023	76,09,077	8,13,944	11.98%	$745,690
29	UBS ASSET MANAGEMENT AMERICAS INC	09/30/2023	73,95,681	-99,02,729	-57.25%	$724,777
30	UBS GROUP AG	09/30/2023	72,35,054	40,440	0.56%	$709,035